These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28539575)

  • 1. Fabry Disease and/or Hypertrophic Cardiomyopathy.
    Anan R
    Int Heart J; 2017 May; 58(3):305-306. PubMed ID: 28539575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predominant cardiac phenotype of Anderson-Fabry disease in presence of a MYBPC3 gene mutation and a LAMA4 gene mutation.
    Laenens D; Koopman P; Cools T
    Acta Cardiol; 2019 Feb; 74(1):84-85. PubMed ID: 29415625
    [No Abstract]   [Full Text] [Related]  

  • 4. Late-onset primary LVH HCM versus cardiac fabry variant.
    Frustaci A; Pieroni M; Chimenti C
    J Am Coll Cardiol; 2002 Apr; 39(8):1405-6; author reply 1406. PubMed ID: 11955864
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
    Nagao Y; Nakashima H; Fukuhara Y; Shimmoto M; Oshima A; Ikari Y; Mori Y; Sakuraba H; Suzuki Y
    Clin Genet; 1991 Mar; 39(3):233-7. PubMed ID: 1645238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy--beyond the sarcomere.
    St John Sutton M; Epstein JA
    N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics of hypertrophic cardiomyopathy in Norway.
    Berge KE; Leren TP
    Clin Genet; 2014 Oct; 86(4):355-60. PubMed ID: 24111713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy.
    Al-Thihli K; Ebrahim H; Hughes DA; Patel M; Tipple M; Salvarinova R; Gardiner J; Vallance H; Waters PJ
    Gene; 2012 Apr; 497(2):320-2. PubMed ID: 22336178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in molecular genetics and management of hypertrophic cardiomyopathy.
    Fananapazir L
    JAMA; 1999 May; 281(18):1746-52. PubMed ID: 10328076
    [No Abstract]   [Full Text] [Related]  

  • 13. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic plasticity of sarcomeric protein mutations.
    Marian AJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2427-9. PubMed ID: 17599606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
    Ackerman MJ; Landstrom AP
    J Am Coll Cardiol; 2007 Dec; 50(25):2404-5. PubMed ID: 18154966
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy and Anderson-Fabry disease: unravelling septal hypertrophy with T1-mapping CMR.
    Edwards NC; Teoh JK; Steeds RP
    Eur Heart J; 2014 Jul; 35(28):1896. PubMed ID: 24713641
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of eosinophilic esophagitis and hypertrophic cardiomyopathy.
    Davis BP; Epstein T; Kottyan L; Amin P; Martin LJ; Maddox A; Collins MH; Sherrill JD; Abonia JP; Rothenberg ME
    J Allergy Clin Immunol; 2016 Mar; 137(3):934-6.e5. PubMed ID: 26441228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of hypertrophic cardiomyopathy: A review of current state.
    Sabater-Molina M; Pérez-Sánchez I; Hernández Del Rincón JP; Gimeno JR
    Clin Genet; 2018 Jan; 93(1):3-14. PubMed ID: 28369730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?
    Ommen SR; Nishimura RA; Edwards WD
    Heart; 2003 Aug; 89(8):929-30. PubMed ID: 12860876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.